Project Number ADDF-57 Agency/Funding Organization Alzheimer's Drug Discovery Foundation Funding Year 2022 View Full Project Details for Discovery of selective LRP1 inhibitors to prevent tau uptake and spread Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 3. Drug Discovery (small molecules and biologics) c. ApoE, Lipids and Lipoprotein Receptors Researcher and Organization Principal Investigator Kosik, Kenneth Principal Investigator First Name Kenneth Principal Investigator Last Name Kosik Awardee Organization University of California, Santa Barbara Awardee State California Contact PI Country United States Project Detail Funding Opportunity Announcement ADDF-Neuroimaging and CSF Biomarkers Program FY Overall Cost $300,000 Funding Organization Agency/Funding Organization Alzheimer's Drug Discovery Foundation Funding Organization Country United States Program Official ADDF Grants Management